Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

2B3-201 as a strategy for sustained and nontoxic release of methylprednisolone

Oct. 9, 2013

Continued clinical benefit of tildrakizumab for 1 year in chronic psoriasis

Oct. 9, 2013

Discovery of novel cathepsin K inhibitors for bone resorption

Oct. 9, 2013

PTC Therapeutics identifies novel fused 2-pyridones active against resistant bacteria

Oct. 9, 2013

First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis

Oct. 9, 2013

HSV-2 vaccine protective in animal challenge model

Oct. 8, 2013

Presentations describe preclinical data on hepatitis B treatment candidate bentysrepinine

Oct. 8, 2013

First-in-human data for the human monoclonal antibody KRN-23

Oct. 8, 2013

LC-510201, a new S1P1/S1P5 receptor agonist for multiple sclerosis

Oct. 8, 2013

Results presented for olaparib in EGFR NSCLC and BRCA-mutated ovarian cancer

Oct. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...